April 15, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Further Shifts in Patent Office Guidance for Discretionary Denials Signal Uphill Battles for Patent Challengers
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Further Shifts in Patent Office Guidance for Discretionary Denials Signal Uphill Battles for Patent Challengers
Biotechnology

Further Shifts in Patent Office Guidance for Discretionary Denials Signal Uphill Battles for Patent Challengers

By Newsroom
Last updated: April 5, 2025
1 Min Read
Share


On the heels of the rescission of the Fintiv guidance memorandum, the U.S. Patent and Trademark Office has again reshaped the PTAB’s approach to discretionary denials. On March 26, 2025, the Acting Director issued a new memorandum that fundamentally changes how the PTAB will handle inter partes review and post grant review petitions

Now, all IPR and PGR institution decisions will be decided in two stages: (1) a threshold analysis focused solely on discretionary denials related to parallel proceedings or issues already decided by the Patent Office; and (2) decisions regarding institution based on the merits of the petition…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

Steps to Improve Press Release Distribution in Environmental Science

Environmental Science
April 9, 2025

Powering Drug Development with Advanced Retrosynthetic…

As small molecule APIs become increasingly complex, longer synthetic pathways present new challenges for process…

April 15, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Eye Therapies v. Slayback Pharma – Fed. Cir. Enhances the Scope of “Consisting Essentially” |

In Eye Therapeutics, LLC, v. Slayback Pharma, LLC., Appeal no. 2023-2173, (Fed. Cir., June 30, 2025), a panel of Judges…

Biotechnology
July 18, 2025

The Future of Biomanufacturing & Bioprocessing and the Role of Press Release Distribution in Market Growth

Biomanufacturing and bioprocessing are revolutionizing the pharmaceutical, agricultural, and industrial sectors by leveraging biological systems for large-scale production. From the…

Biomanufacturing & bioprocessingBiotechnology
August 30, 2025

The Future of Marketing in the Biotechnology Industry: The Role of Press Release Distribution

The biotechnology industry is experiencing rapid advancements in gene editing, personalized medicine, synthetic biology, and biopharmaceuticals. As the industry expands,…

Biotechnology
April 9, 2025

Federal March-In Rights Meet Clawbacks – The Future of 35 USC ss. 200-212 |

This post could have been “The Revival of the March-In Rights of the Bayh-Dole Act.” The passage of the Bayh-Dole…

Biotechnology
April 26, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

Powering Drug Development with Advanced Retrosynthetic…
April 15, 2026
AI and Model-Based Tools to Streamline Drug Development
April 15, 2026
Q&A on large-scale commercial expansion at Lonza's Stein…
April 15, 2026
Distribute Your Drug-Manufacturing Risk and Increase Supply…
April 14, 2026

Life Science Magazines

Powering Drug Development with Advanced Retrosynthetic…
April 15, 2026
AI and Model-Based Tools to Streamline Drug Development
April 15, 2026
Q&A on large-scale commercial expansion at Lonza's Stein…
April 15, 2026
Distribute Your Drug-Manufacturing Risk and Increase Supply…
April 14, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?